google-site-verification: googlec7193c3de77668c9.html

Prevalence of high total cholesterol 11.3% in US adults from Aug. 2021–Aug. 2023

Prevalence of high total cholesterol 11.3 percent in U.S. adults

The prevalence of high total cholesterol was 11.3% among U.S. adults from August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Margaret D. Carroll, M.S.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues presented the prevalence of high total cholesterol and low high-density lipoprotein cholesterol (HDL-C) by sex and age group for adults aged 20 years and older using data from the 2021 to 2023 National Health and Nutrition Examination Survey.

The researchers found that the prevalence of high total cholesterol was 11.3% in adults during August 2021 to August 2023, with no significant difference between men and women (10.6 and 11.9%). The prevalence of low HDL-C was 13.8% for adults and was higher in men than women (21.5 versus 6.6%) and decreased with age. The prevalence of high total cholesterol decreased from 1999-2000 to 2013-2014, with no significant change thereafter. The prevalence of low HDL-C decreased from 2007-2008 to August 2021-August 2023.

“The prevalence of high total cholesterol was higher in men ages 40 to 59 than in men ages 20 to 39 and 60 and older, and higher in women ages 40 to 59 and 60 and older than in women ages 20 to 39,” the authors write.

More information:
Abstract/Full Text

2024 HealthDay. All rights reserved.

Citation:
Data brief: Prevalence of high total cholesterol 11.3% in US adults from Aug. 2021–Aug. 2023 (2024, November 20)
retrieved 21 November 2024
from https://medicalxpress.com/news/2024-11-prevalence-high-total-cholesterol-adults.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Advertisements




medicalxpress.com

Views: 2

See also  Pfizer poised to buy Metsera in $10 bn deal after bidding war

Check Also

How PM2.5 exposure fuels bladder cancer progression

[ The systemic journey of inhaled PM2.5 particles from the respiratory system down to the …

Study reveals how early-life cellular process helps shape lifelong immune health

[ Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the …

Resident doctors in England accept pay deal and end strikes

Resident doctors in England have voted to accept the government’s offer on pay and jobs, …

Leave a Reply

Available for Amazon Prime